Most importantly, however, the results of LDTs and particularly the SP142 assay appeared discordant, with proportionately fewer PD-L1 tumor expression results of ≥50%, suggesting that some cases of NSCLC with high PD-L1 tumor expression could have been missed. Here, CD274 is linked to neoplasm.